SAIT’s submission on the draft amendments to Part 1 of Schedule No. 1 welcomes SARS’s initiative to insert Additional Notes and new tariff subheadings to clarify the treatment of herbal and homeopathic medicinal preparations under heading 3004. SAIT views this as a positive step toward resolving long-standing ambiguity in the customs clearance process, which has caused delays due to inconsistent interpretations and lack of awareness about SAHPRA requirements. However, it raises concerns about the duplication of SAHPRA references in the draft and seeks clarification on licensing requirements. Additionally, SAIT stresses the need for coordination between SARS and other government agencies (OGAs) to prevent conflicting information between tariff schedules and the published list of prohibited and restricted goods.
READ MORE
